OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - MEDGENICS INC ownership

MEDGENICS INC's ticker is MDGN and the CUSIP is 58436Q203. A total of 69 filers reported holding MEDGENICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of MEDGENICS INC
ValueSharesWeighting
Q2 2016$278,000,00050,0000.01%
Other shareholders
MEDGENICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Belmont Global Advisors, Inc. 330,000$1,977,0001.60%
CARL DOMINO INC 21,282$127,0000.07%
WHITE PINE CAPITAL LLC 40,000$240,0000.04%
Perceptive Advisors 61,263$367,0000.04%
HYMAN CHARLES D 14,500$87,0000.02%
Kavar Capital Partners, LLC 2,000$11,0000.01%
WFG Advisors, LP 10,000$60,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 40,000$240,0000.01%
Legal & General Group Plc 725,000$4,293,0000.01%
Pinnacle Summer Investments, Inc. 5,250$31,0000.00%
View complete list of MEDGENICS INC shareholders